You are here

Drug switch study bolsters case for using copies of biotech medicine


NEW clinical data has bolstered the case for using cheaper copies of expensive biotech drugs by showing that patients with rheumatic diseases can be safely and effectively switched from original-brand medicine to a lower-cost version.

While the first copies of a blockbuster

Market voices on:

Powered by GET.comGetCom